Compound Detail
CHEMBL4528598
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1cc([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)N2CCC(N3CCC(C#Cc4ccc(C(=O)N[C@H]5C(C)(C)[C@H](Oc6ccc(C#N)c(Cl)c6)C5(C)C)cc4)CC3)CC2)c2ccc(-c3scnc3C)cc2)C(C)C)on1
Basic Information
| ChEMBL ID | CHEMBL4528598 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RGPUSLXMPBTXNU-MLMZQBPXSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
5
Publications
0
Known Names
Molecular Properties
1095.8
MW (Da)
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 8.7
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| LNCaP | IC50 | = | 2.0 | nM | 8.7 | Antiproliferative activity against AR-positive human LNCAP cells incubated for 7... | 31804827 |
| VCaP | IC50 | = | 2.0 | nM | 8.7 | Antiproliferative activity against AR- positive human VCaP cells incubated for 7... | 31804827 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31804827 | 10.1021/acs.jmedchem.9b01393 | von Hippel-Lindau disease tumor suppressor/Androgen receptor | 7 |
| 33738051 | 10.1021/acsmedchemlett.1c00059 | von Hippel-Lindau disease tumor suppressor/Androgen receptor | 3 |
| 30629437 | 10.1021/acs.jmedchem.8b01631 | von Hippel-Lindau disease tumor suppressor/Androgen receptor | 3 |
| 31804827 | 10.1021/acs.jmedchem.9b01393 | LNCaP | 1 |
| 31804827 | 10.1021/acs.jmedchem.9b01393 | VCaP | 1 |
Data from ChEMBL 36 via Core Engine